DMAAR NASDAQ
Drugs Made In America Acquisition Corp. Rights
1W: +2.0%
1M: -1.9%
3M: +15.9%
YTD: -28.4%
1Y: -41.5%
$0.13
+0.00 (+0.87%)
Weekly Expected Move ±21.1%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$6M
Net Income
+72.0% YoY
$-0M
Free Cash Flow
+41.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE3.3%
ROA3.2%
ROIC-1.9%
Valuation
P/E55.4
P/B1.6
EV/EBITDA-1.2
Leverage
Debt/Equity0.01
Current Ratio0.02
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z-0.01
Beneish M0.00